Coulter Partners

About Us

Coulter Partners provides leadership consultancy to Life Sciences, Health and Technology innovation businesses globally. We build teams that change the world and create a better future. Over 20 years we have delivered on 1000s of assignments across the USA, Canada, UK/Europe, and APAC, advising companies and investors on how to shape and hire their boards and leadership teams. We strongly impact value and growth. Our 110 experts operate uniquely as one global team. With our track record, AI, bespoke systems and wealth of data, we fuel the ability of investors, boards and executive teams to deliver value from innovation.

Achievements

Recent Placements

Coulter Partners

Find a Recruiter

0

The Coulter Partners team is made up of 110 experts, working in 40 countries, holding 250,000 conversations with industry leaders each year. Together we channel data and learning to the benefit of our clients. We are a diverse group of experts with backgrounds ranging from science and technology, to the arts, finance, and more. Our reward system is designed to drive one-team behaviors and we work together seamlessly to combine industry experience and global insight with our passion for progress. Our team understands and is up to date with the challenges you face and the opportunities your business can maximize. This means we can find and develop exceptional individuals to drive you forward.

Our Team

Coulter Partners

Solutions And Expertise

Our network is carefully curated and gives us access to leaders who can guide science, technology and innovation-driven companies through all stages of growth and evolution. Our executive search is an end-to-end process, underpinned by rigorous data and analytics from our dedicated Business Intelligence function and CP:Net™, our proprietary AI-driven candidate and company database.  Our Board Advisory brings over two decades’ experience in building, advising and evolving boards for private and public companies. We understand what value a board can bring and how to evaluate its suitability for the stage of the business and the 3–5-year plan. We also provide leadership advisory at every step of the way. We have a network of mentors and advisors that bring the next level of insight to your organization, to build teams that change the world.

Solutions
  • Advisory Services
  • Assessment
  • Board Services
  • Culture Shaping
  • Data Analy./Mrkt. Intell.
  • Diversity & Inclusion
  • Executive Coaching
  • Executive Search
  • Leadership Consulting
  • Leadership Develop.
  • Mgmt. Consulting
  • Onboarding
  • Recruitment Research
  • Succession Planning
Industries
  • Agriculture
  • Biotechnology
  • Chemicals
  • Clean Tech./Sustain.
  • Clinical Research
  • Consulting
  • Consumer
  • Consumer Products
  • Consumer Services
  • Data & Analytics
  • Devices
  • Energy
  • Family Offices
  • Financial Services
  • FinTech
  • Foundations
  • Healthcare Services
  • High Tech
  • Industrial
  • Industrial Products
  • Internet
  • Life Sci./Healthcare
  • Machine Learning
  • Medical
  • Medical Devices
  • Natural Resources
  • Non-Profit
  • Pharmaceuticals
  • Private Equity
  • Professional Services
  • Software
  • Supply Chain
  • Technology
  • Venture Capital
Functions
  • Board/Governance
  • Business Development
  • CEO/President
  • Data/Analytics
  • Diversity & Inclusion
  • Finance/Accounting
  • General Management
  • GM/Operations
  • Human Resources
  • Information/Digital
  • Investor Relations
  • Legal/Compliance
  • Manufacturing
  • Marketing & Sales
  • Medical/Clinical
  • Research & Develop.
  • Supply Chain

Coulter Partners

News Briefings

Coulter Partners Recruits CEO and Chief Business Officer for IMU Biosciences

Life sciences recruiting specialist Coulter Partners has helped to recruit John Baker as chief executive officer and Jason Brown as chief business officer of biotechnology company IMU Biosciences. Founder and past CEO Adam Laing will assume the roles of president and chief scientific officer. “I am incredibly proud of what the IMU team has achieved to date,” said

Coulter Partners Recruits CEO for Nitinotes

Life sciences recruiting specialist Coulter Partners has assisted in the recruitment of Lloyd Diamond as the new CEO of Nitinotes Surgical in Caesarea, Israel. He succeeds Raz Bar-On, who will continue as  general manager. “We are thrilled to welcome Lloyd to lead Nitinotes into its next chapter of innovation and growth,” said John Barr, chairman of the

Coulter Partners Recruits Chief Development Officer for CellCentric

Chief development officers are crucial to life sciences organizations as they drive strategic planning and oversee the development of new products and therapies, ensuring alignment with market needs. They foster collaboration across research, regulatory, and commercial teams to streamline innovation and accelerate time to market. Finding these executives has kept executive search firms busy. Life

Coulter Partners Recruits CEO for Tristel

Life sciences recruiting specialist Coulter Partners has assisted in the recruitment of Matthew Sassone as the new CEO of Tristel plc, a manufacturer of infection prevention products. He will replace Paul Swinney, the company’s founder and CEO of 30 years, who announced his plans to retire during 2023. Mr. Swinney will remain with the company for a suitable

Coulter Partners

Press Releases

Coulter Partners strengthens Curve Therapeutics’ leadership team with appointment of Chief R&D Officer

Coulter Partners successfully completed a search assignment for Curve Therapeutics (“Curve”) and is pleased to announce the placement of Rab Prinjha, PhD, as Chief Research and Development (R&D) Officer. Curve Therapeutics is a private biotechnology company pioneering a revolutionary mammalian cell-based, functional drug discovery platform to address intracellular disease targets. Its mission is to improve

Coulter Partners Secures Senior Vice President of Partnerships for Entia

Coulter Partners successfully completed a search assignment for Entia and is pleased to announce the placement of Timothy Broke-Smith as Senior Vice President of Partnerships. Working at the frontiers of remote patient monitoring and predictive analytics, Entia has combined novel at-home blood testing technology and digital solutions to deliver personalized insights into cancer patients’ journeys

Coulter Partners Secures Industry-Leading Chief Medical Officer for Solu Therapeutics

Coulter Partners recently partnered with Solu Therapeutics (Solu) and is pleased to announce the placement of Sergio Santillana, MD, MSc, MBA, as Chief Medical Officer (CMO). Solu Therapeutics is a biotechnology company pioneering novel therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas. As CMO, Dr. Santillana will oversee strategic direction and

Coulter Partners Strengthens Leadership at IMU Biosciences with Placements of Chief Executive Officer and Chief Business Officer

Coulter Partners recently partnered with IMU Biosciences and is pleased to announce the placements of Dr. John Baker as Chief Executive Officer and Dr. Jason Brown as Chief Business Officer. Founder and former Chief Executive Officer Dr. Adam Laing will assume the roles of President and Chief Scientific Officer. IMU Biosciences is a biotechnology company

Coulter Partners places new Chair at ArcticZymes Technologies

Coulter Partners successfully completed a search assignment for ArcticZymes Technologies ASA (OSE: AZT) and is pleased to announce the placement of Dr. Frank Mathias as Chair of the Board. Dr. Mathias is the CEO at Oxford Biomedica, a leading pure-play CDMO within the cell and gene therapy industry. Dr. Mathias was previously the CEO of

Coulter Partners

Multimedia

News
Top global hires for large-cap, mid-cap and public companies H2-2024
Coulter Partners attends AESC Global Conference: Inspire. Innovate. Impact.
Coulter Partners hosts inaugural annual partners meeting
Top hires for VC & PE portfolio companies Q3-2024
Packed house for Coulter Partners’ latest HealthTech Ecosystem breakfast
Coulter Partners runs Vitality 10K to raise money for Kith & Kids charity
Top hires for VC & PE portfolio companies Q2-2024
Top global hires for large-cap, mid-cap and public companies H1-2024
D, E & I: VIEWS FROM LEADERSHIP SERIES – Ankit Mahadevia, MD, Founder and Chair of Spero Therapeutics, and author of Quiet Leader, Loud Results
Top hires for VC & PE portfolio companies Q1-2024
D, E & I: VIEWS FROM LEADERSHIP SERIES – Lene Gerlach, Founder and Chair of Women in Life Science Denmark (WiLD), and Partner at Eir Ventures
D, E & I: VIEWS FROM LEADERSHIP SERIES – Yael Gruenbaum-Cohen, Partner at aMoon and Founder of WE@HealthTech
Top hires for VC & PE portfolio companies Q4-2023
Top global hires for large-cap, mid-cap and public companies H2-2023
Top hires for VC & PE portfolio companies Q3-2023
Top hires for VC & PE portfolio companies Q2-2023
Top global hires for large-cap, mid-cap and public companies H1-2023
Top hires for VC & PE portfolio companies Q1-2023
D, E & I: Views From Leadership Series – Charlotte Valeur, Founder of Institute Of Neurodiversity, ION
Top hires for VC & PE portfolio companies Q4-2022
Top global hires for large-cap, mid-cap and public companies H2-2022
Diversity, Equity, & Inclusion: Views From Leadership Series- Quita Highsmith, Vice President and Chief Diversity Officer at Genentech
Diversity, Equity & Inclusion: Views from Leadership-Tomoko Adachi
Diversity, Equity & Inclusion: Views from Leadership-Corinne Le Goff